Salivary Analysis of Oral Cancer Biomarkers

Overview

Journal Br J Cancer

Specialty Oncology

Date 2009 Oct 1

PMID 19789535

Citations 68

Authors

T Shpitzer

Y Hamzany

G Bahar

R Feinmesser

D Savulescu

I Borovoi

M Gavish

R M Nagler

Affiliations

Soon will be listed here.

Abstract

Background: Oral cancer is a common and lethal malignancy. Direct contact between saliva and the oral cancer lesion makes measurement of tumour markers in saliva an attractive alternative to serum testing.

Methods: We tested 19 tongue cancer patients, measuring the levels of 8 salivary markers related to oxidative stress, DNA repair, carcinogenesis, metastasis and cellular proliferation and death.

Results: Five markers increased in cancer patients by 39-246%: carbonyls, lactate dehydrogenase, metalloproteinase-9 (MMP-9), Ki67 and Cyclin D1 (CycD1) (P< or =0.01). Three markers decreased by 16-29%: 8-oxoguanine DNA glycosylase, phosphorylated-Src and mammary serine protease inhibitor (Maspin) (P< or =0.01). Increase in salivary carbonyls was profound (by 246%, P=0.012); alterations in CycD1 (87% increase, P=0.000006) and Maspin (29% decrease, P=0.007) were especially significant. Sensitivity values of these eight analysed markers ranged from 58% to 100%; specificity values ranged from 42% to 100%. Both values were especially high for the CycD1 and Maspin markers, 100% for each value of each marker. These were also high for carbonyls, 90% and 80%, respectively, and for MMP-9, 100% and 79%, respectively.

Conclusion: The significance of each salivary alteration is discussed. As all alterations correlated with each other, they may belong to a single carcinogenetic network. Cancer-related changes in salivary tumour markers may be used as a diagnostic tool for diagnosis, prognosis and post-operative monitoring.

Citing Articles

Saliva and serum biomarkers in oral diseases: A case-control study.

Al Shaar A, Hamadeh O, Ali A Medicine (Baltimore). 2025; 103(52):e41072.

PMID: 39969370 PMC: 11688012. DOI: 10.1097/MD.0000000000041072.

Salivary miRNAs and cytokines associated with diagnosis and prognosis of oral squamous cell carcinoma.

Qin Y, Dong X, Li B Front Cell Dev Biol. 2025; 13:1531016.

PMID: 39911325 PMC: 11794800. DOI: 10.3389/fcell.2025.1531016.

Serum Concentration of MMP-9 as a Predictive Biomarker for the Progression of Oral Cancer.

Saini J, Bakshi J, Panda N, Sharma M, Yadav A, Kamboj K J Maxillofac Oral Surg. 2024; 23(5):1079-1088.

PMID: 39376770 PMC: 11455997. DOI: 10.1007/s12663-023-01932-5.

Salivary biomarkers in non-invasive oral cancer diagnostics: a comprehensive review.

Vats R, Yadav P, Bano A, Wadhwa S, Bhardwaj R J Appl Oral Sci. 2024; 32:e20240151.

PMID: 39258715 PMC: 11464085. DOI: 10.1590/1678-7757-2024-0151.

Evaluation of Serum and Salivary Lactate Dehydrogenase Levels in Patients with Oral Potentially Malignant Conditions/Lesions: A Clinical and Biochemical Study.

Rao K, Babu S, Shetty S, Castelino R Indian J Community Med. 2024; 49(2):316-321.

PMID: 38665466 PMC: 11042121. DOI: 10.4103/ijcm.ijcm_612_22.

References

Shpitzer T, Bahar G, Feinmesser R, Nagler R . A comprehensive salivary analysis for oral cancer diagnosis. J Cancer Res Clin Oncol. 2007; 133(9):613-7. DOI: 10.1007/s00432-007-0207-z. View

Tuzgen S, Hanimoglu H, Tanriverdi T, Kacira T, Sanus G, Atukeren P . Relationship between DNA damage and total antioxidant capacity in patients with glioblastoma multiforme. Clin Oncol (R Coll Radiol). 2007; 19(3):177-81. DOI: 10.1016/j.clon.2006.11.012. View

Avizienyte E, Brunton V, Fincham V, Frame M . The SRC-induced mesenchymal state in late-stage colon cancer cells. Cells Tissues Organs. 2005; 179(1-2):73-80. DOI: 10.1159/000084511. View

Ribeiro K, Kowalski L, Latorre M . Impact of comorbidity, symptoms, and patients' characteristics on the prognosis of oral carcinomas. Arch Otolaryngol Head Neck Surg. 2000; 126(9):1079-85. DOI: 10.1001/archotol.126.9.1079. View

Sparano A, Weinstein G, Chalian A, Yodul M, Weber R . Multivariate predictors of occult neck metastasis in early oral tongue cancer. Otolaryngol Head Neck Surg. 2004; 131(4):472-6. DOI: 10.1016/j.otohns.2004.04.008. View

Hanimoglu H, Tanriverdi T, Kacira T, Sanus G, Atukeren P, Aydin S . Relationship between DNA damage and total antioxidant capacity in patients with transitional meningioma. Clin Neurol Neurosurg. 2007; 109(7):561-6. DOI: 10.1016/j.clineuro.2007.04.007. View

Wang L, Liu T, Nishioka M, Aguirre R, Swe Swe Win , Okada N . Activation of ERK1/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: relationship between clinicopathological appearances and cell proliferation. Oral Oncol. 2006; 42(6):625-31. DOI: 10.1016/j.oraloncology.2005.11.002. View

Cho J, Kim H, Park C, Kim J, Jung K, Shin B . Maspin expression in early oral tongue cancer and its relation to expression of mutant-type p53 and vascular endothelial growth factor (VEGF). Oral Oncol. 2006; 43(3):272-7. DOI: 10.1016/j.oraloncology.2006.03.018. View

Paz-Elizur T, Sevilya Z, Leitner-Dagan Y, Elinger D, Roisman L, Livneh Z . DNA repair of oxidative DNA damage in human carcinogenesis: potential application for cancer risk assessment and prevention. Cancer Lett. 2008; 266(1):60-72. PMC: 2563153. DOI: 10.1016/j.canlet.2008.02.032. View

10.

Vairaktaris E, Vassiliou S, Nkenke E, Serefoglou Z, Derka S, Tsigris C . A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol. 2007; 34(4):450-5. DOI: 10.1016/j.ejso.2007.03.024. View

11.

Schneider J . Tumor markers in detection of lung cancer. Adv Clin Chem. 2006; 42:1-41. DOI: 10.1016/s0065-2423(06)42001-1. View

12.

Iezzi G, Piattelli A, Rubini C, Goteri G, Artese L, Perrotti V . Maspin expression in oral squamous cell carcinoma. J Craniofac Surg. 2007; 18(5):1039-43. DOI: 10.1097/scs.0b013e31814b2a36. View

13.

Myers J, Elkins T, Roberts D, Byers R . Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg. 2000; 122(1):44-51. DOI: 10.1016/S0194-5998(00)70142-2. View

14.

Pories S, Zurakowski D, Roy R, Lamb C, Raza S, Exarhopoulos A . Urinary metalloproteinases: noninvasive biomarkers for breast cancer risk assessment. Cancer Epidemiol Biomarkers Prev. 2008; 17(5):1034-42. DOI: 10.1158/1055-9965.EPI-07-0365. View

15.

Duffy M, Crown J . A personalized approach to cancer treatment: how biomarkers can help. Clin Chem. 2008; 54(11):1770-9. DOI: 10.1373/clinchem.2008.110056. View

16.

Yuen P, Lam K, Chan A, Wei W, Lam L . Clinicopathological analysis of local spread of carcinoma of the tongue. Am J Surg. 1998; 175(3):242-4. DOI: 10.1016/s0002-9610(97)00282-1. View

17.

Paz-Elizur T, Ben-Yosef R, Elinger D, Vexler A, Krupsky M, Berrebi A . Reduced repair of the oxidative 8-oxoguanine DNA damage and risk of head and neck cancer. Cancer Res. 2006; 66(24):11683-9. DOI: 10.1158/0008-5472.CAN-06-2294. View

18.

Kosunen A, Pirinen R, Ropponen K, Pukkila M, Kellokoski J, Virtaniemi J . CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma. Oral Oncol. 2006; 43(1):51-9. DOI: 10.1016/j.oraloncology.2006.01.003. View

19.

Marioni G, Gaio E, Giacomelli L, Bertolin A, DAlessandro E, Stramare R . MASPIN subcellular localization and expression in oral cavity squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2008; 265 Suppl 1:S97-104. DOI: 10.1007/s00405-008-0583-2. View

20.

Kantola S, Parikka M, Jokinen K, Hyrynkangs K, Soini Y, Alho O . Prognostic factors in tongue cancer - relative importance of demographic, clinical and histopathological factors. Br J Cancer. 2000; 83(5):614-9. PMC: 2363505. DOI: 10.1054/bjoc.2000.1323. View